Stockreport

Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]

Kiromic BioPharma, Inc.  (KRBP) 
PDF HOUSTON, January 29, 2024 BUSINESS WIRE Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports favorable early efficacy results from the first patie [Read more]